Timothy Powers, Chief Scientific Officer
Timothy Powers, PhD, is the Chief Scientific Officer of Mount Tam Biotechnologies. Dr. Powers has been engaged in all aspects of drug discovery and development for more than 20 years at both small and large biotechnology and pharmaceutical companies.
Most recently, Dr. Powers held the position of Scientific Director of Medicinal Chemistry at Amgen where he provided scientific and executive leadership to the teams that were responsible for the discovery and development of Amgen’s first ß-secretase small-molecule clinical candidate for Alzheimer’s disease. Prior to joining Amgen, he was Director of Medicinal Chemistry at Alantos Pharmaceuticals, overseeing all aspects of the company’s discovery research activities which led to the clinical development of the company’s two flagship programs in the areas of type-II diabetes and osteoarthritis. Alantos was purchased by Amgen for $300M, and Dr. Powers was integral to the transaction.
Dr. Powers has authored over 50 publications and scientific presentations and is an inventor on over 40 issued U.S. patents and patent applications in the areas of drug discovery and process manufacturing spanning therapeutic disease areas of inflammation, neuroscience, oncology and metabolic diseases. He holds a B.S. degree in Chemistry from the University of California, Davis and received his Ph.D. in Organic Chemistry from the University of Chicago.